Search results

309 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Evans talks about DNA analysis on HuffPost Live
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, provided his perspective on a HuffPost Live broadcast that aired on September 24, 2012.
Located in News / 2012 News
UNC Lineberger scientists lead cancer genome analysis of breast cancer
Team identifies genetic causes and similarity to ovarian cancer
Located in News / 2012 News
Carey named Division Chief of Hematology-Oncology and Physician-in-Chief of the N.C. Cancer Hospital
Chapel Hill - Lisa A. Carey, MD, has been appointed Chief of the Division of Hematology and Oncology at the University of North Carolina School of Medicine and Physician-in-Chief of the N.C. Cancer Hospital.
Located in News / 2012 News
Informatics approach helps doctors, patients make sense of genome data
Chapel Hill, NC – The cost of sequencing the entire human genome, or exome – the regions of the genome that are translated into proteins that affect cell behavior – has decreased significantly, to the point where the cost of looking at the majority of a patient’s genomic data may be less expensive than undertaking one or two targeted genetic tests.
Located in News / 2012 News
Diseases of aging map to a few ‘hotspots’ on the human genome
Chapel Hill, NC –Researchers have long known that individual diseases are associated with genes in specific locations of the genome.
Located in News / 2012 News
NPR series focuses on gene sequencing, Evans comments
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, is quoted in NPR's second story in its "$1,000 Genome" series, which aired today.
Located in News / 2012 News
Genetically-engineered preclinical models predict pharmacodynamic response
Preclinical testing a necessary step in drug development
Located in News / 2012 News
UNC Lineberger faculty co-author review article on adjuvant chemotherapy in women 70 years of age and older
Located in News / 2012 News
Tate appointed to term on Psychosocial Risk and Disease Prevention Study Section
Located in News / 2012 News
Cell death mystery yields new suspect for cancer drug development
Chapel Hill, NC – A mysterious form of cell death, coded in proteins and enzymes, led to a discovery by UNC researchers uncovering a prime suspect for new cancer drug development.
Located in News / 2012 News